INVIGORATE: A Study of QL1706 and Bevacizumab in Advanced First-Line Ovarian Clear Cell Carcinoma
Clinical trial NCT07002346 · RECRUITING
Trial details
- NCT number
- NCT07002346
- Sponsor
- Tongji Hospital
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-15
- Primary completion
- 2027-06-01
- Enrollment
- 226
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.